Bank of New York Mellon Corp - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 57 filers reported holding SORRENTO THERAPEUTICS INC in Q1 2015. The put-call ratio across all filers is 1.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$1,363,041
-34.0%
1,538,421
+17.0%
0.00%
Q3 2022$2,064,000
-15.1%
1,314,634
+8.7%
0.00%
-100.0%
Q2 2022$2,430,000
+5.8%
1,209,139
+22.7%
0.00%
Q1 2022$2,297,000
-48.4%
985,502
+2.8%
0.00%
-100.0%
Q4 2021$4,455,000
-49.8%
958,261
-17.6%
0.00%
-50.0%
Q3 2021$8,869,000
-9.7%
1,162,385
+14.7%
0.00%0.0%
Q2 2021$9,818,000
+30.7%
1,013,177
+11.6%
0.00%0.0%
Q1 2021$7,511,000
+18.5%
908,251
-2.2%
0.00%
+100.0%
Q4 2020$6,337,000
-24.8%
928,428
+22.9%
0.00%
-50.0%
Q3 2020$8,423,000
+107.4%
755,438
+16.8%
0.00%
+100.0%
Q2 2020$4,061,000
+435.8%
646,704
+56.9%
0.00%
Q1 2020$758,000
-44.6%
412,097
+1.9%
0.00%
Q4 2019$1,367,000
+47.6%
404,464
-6.5%
0.00%
Q3 2019$926,000
-23.5%
432,528
-4.5%
0.00%
Q2 2019$1,210,000
-41.6%
453,057
+3.9%
0.00%
-100.0%
Q1 2019$2,071,000
+104.2%
436,151
+3.2%
0.00%
Q4 2018$1,014,000
-42.0%
422,451
+6.3%
0.00%
Q3 2018$1,749,000
-22.3%
397,366
+27.2%
0.00%
-100.0%
Q2 2018$2,250,000
+637.7%
312,419
+429.0%
0.00%
Q1 2018$305,000
+47.3%
59,059
+8.2%
0.00%
Q4 2017$207,000
+263.2%
54,598
+62.8%
0.00%
Q3 2017$57,000
+1.8%
33,534
+20.2%
0.00%
Q2 2017$56,000
-90.5%
27,888
-81.3%
0.00%
Q1 2017$590,000
-19.6%
149,424
-0.2%
0.00%
Q4 2016$734,000
-15.1%
149,755
+34.1%
0.00%
Q3 2016$865,000
+31.1%
111,703
-5.2%
0.00%
Q2 2016$660,000
+3.9%
117,846
-0.0%
0.00%
Q1 2016$635,000
-18.7%
117,891
+31.5%
0.00%
Q4 2015$781,000
-0.1%
89,643
-3.8%
0.00%
Q3 2015$782,000
-74.0%
93,204
-45.4%
0.00%
-100.0%
Q2 2015$3,008,000
+1103.2%
170,723
+689.0%
0.00%
Q1 2015$250,000
+60.3%
21,639
+39.4%
0.00%
Q4 2014$156,000
+194.3%
15,521
+32.5%
0.00%
Q3 2014$53,000
-66.5%
11,716
-50.0%
0.00%
Q2 2014$158,00023,4320.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Cormorant Asset Management, LP 6,000,000$66,900,0002.57%
SABBY MANAGEMENT, LLC 606,298$6,760,0001.01%
Virtus ETF Advisers LLC 66,851$745,0000.39%
Newbridge Financial Services Group, Inc. 26,900$300,0000.30%
Avidian Wealth Solutions, LLC 330,000$3,680,0000.28%
Spectrum Wealth Advisory Group, LLC 36,692$422,0000.27%
COWEN AND COMPANY, LLC 129,200$1,441,0000.24%
Cormorant Asset Management, LP 500,000$5,575,0000.21%
SYMMETRY PEAK MANAGEMENT LLC 27,500$307,0000.20%
Aristides Capital LLC 24,302$271,0000.19%
View complete list of SORRENTO THERAPEUTICS INC shareholders